Startup entity
product-launch is the sole category represented across all 1 tracked stories. Geneva is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each story carries 2 original sources on average, compared with 2.4 for the broader beat in this window.
Last mentioned: Mar 9, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
product-launch is the sole category represented across all 1 tracked stories. Geneva is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each story carries 2 original sources on average, compared with 2.4 for the broader beat in this window. Their average consequence score of 7 runs above the beat's 6.7 for that window. GOOD Vision oka³y ! ™ appears in 1 tracked Startup story from March 9, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 43 Startup stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering GOOD Vision oka³y ! ™. Shared-story counts are live from our verified record — not editorial picks.
Market Expansion
Anticipated regulatory filings and distribution partnership announcements.
Global Debut
GOOD Vision oka³y ! ™ officially launches in Geneva.
Research Phase
Development of freeform orthokeratology algorithms at PolyU.
GOOD Vision oka³y ! ™, a high-precision medtech startup originating from The Hong Kong Polytechnic University, has launched its freeform orthokeratology solution at a global debut in Geneva. The technology represents a significant advancement in personalized myopia control, transitioning from academic research to a commercialized medical device.
GOOD Vision oka³y ! ™ is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
